Search results

A step-by-step summary about how we develop our technology appraisal guidance.

Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.

NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.

Information and benefits about shared decision making. Includes links to patient decision aids.

Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.

Home What NICE does Our guidance Modular updates {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem"

Over the next year, our prioritisation decisions will be shaped by the government’s strategic direction for health and life sciences, and by the needs of the NHS, local systems and the people who use services.

An approximate guide to the timings for the development of a piece of HealthTech guidance.

Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.

We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.

All the templates and supporting documents you need to make a technology appraisals submission with NICE.

We work with the Terminology and Classifications delivery service of NHS England to provide relevant clinical coding information for interventional procedures guidance.

People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.

The guidance development timeline

NICE guidelines are evidence-based recommendations for health and care in England and Wales.